Form4insider filings, from the source

SEC Form 4 · accession 0000914190-26-000133

BIO-TECHNE Corp · TECH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kim Kelderman
Officer — Chief Executive Officer · Director
Period of report
Aug 17, 2026
Accepted (ET)
Aug 19, 2026 · 4:48 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000842023

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———82,762D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF7,F12—Aug 17, 2026A57,590A——Common Stock57,59057,590D
Restricted Stock UnitsF7,F13—Aug 17, 2026A93,582A——Common Stock93,58293,582D
Stock Option (Right to Buy)F1$66.97holding————Aug 5, 2027Common Stock115,724115,724D
Stock Option (Right to Buy)F1$120.46holding————Aug 6, 2028Common Stock25,94425,944D
Stock Options (Right to Buy)F1$94.52holding————Aug 15, 2029Common Stock28,94028,940D
Stock Options (Right to Buy)F1$84.61holding————Aug 15, 2030Common Stock1,4921,492D
Stock Options (Right to Buy)F2$84.61holding————Aug 15, 2030Common Stock29,39129,391D
Stock Options (Right to Buy)F3$52.83holding————Nov 1, 2030Common Stock38,25238,252D
Stock Options (Right to Buy)F1$68.54holding————Feb 1, 2031Common Stock1,6211,621D
Stock Options (Right to Buy)F4$68.54holding————Feb 1, 2031Common Stock51,89051,890D
Stock Options (Right to Buy)F5$74.91holding————Aug 15, 2034Common Stock69,06169,061D
Stock Options (Right to Buy)F6$53.60holding————Aug 15, 2035Common Stock90,44190,441D
Performance Restricted Stock UnitsF7,F8—holding—————Common Stock51,26151,261D
Performance Restricted Stock UnitsF7,F9—holding—————Common Stock70,70870,708D
Restricted Stock UnitsF7,F10—holding—————Common Stock8,5448,544D
Restricted Stock UnitsF7,F11—holding—————Common Stock23,56923,569D

Explanation of responses